Literature DB >> 10430394

DNA content by flow cytometry in gastric carcinoma: pathology, ploidy and prognosis.

F Esteban1, D S de Vega, R Garcia, R Rodriguez, J Manzanares, A Almeida, S Tamames.   

Abstract

BACKGROUND/AIMS: The prognostic relevance of histopathologic findings in gastric carcinoma is well established. Studies on DNA-ploidy are still scanty and contradictory.
METHODOLOGY: Histopathologic parameters, DNA ploidy and S-phase were evaluated in 78 cancer patients curatively resected, using formalin-fixed paraffin-embedded tissue.
RESULTS: Thirty-nine tumors (50%) were aneuploid. No significant correlation was found between histologic data and ploidy, but tumors with nodal involvement were more frequently aneuploid. In univariate analysis, tumor location (p=0.05), tumor size (p=0.01), differentiation grade (p=0.02), Lauren classification (p=0.01), deeper infiltration of gastric wall (p=0.001), nodal affectation (p=0.0000) and number of lymph nodes (p=0.01), TNM stage (p=0.0000), type of gastrectomy performed (p=0.04), and DNA ploidy (p=0.04) significantly influenced survival. S-phase values had no effect on prognosis. In the multiple regression model, factors independently associated with survival were TNM stage (p=0.0009), nodal affectation (p=0.01) and, marginally, ploidy (p=0.08).
CONCLUSIONS: In gastric carcinoma curatively resected, the more relevant prognostic factors were stage and nodal involvement. Fifty percent of the tumors were aneuploid. Aneuploidy was significantly associated with poorer prognosis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10430394

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  3 in total

Review 1.  Clinical impact of aneuploidy on gastric cancer patients.

Authors:  Isabel Sánchez-Pérez; Pilar García Alonso; Cristóbal Belda Iniesta
Journal:  Clin Transl Oncol       Date:  2009-08       Impact factor: 3.405

2.  Tumour-amplified kinase BTAK is amplified and overexpressed in gastric cancers with possible involvement in aneuploid formation.

Authors:  C Sakakura; A Hagiwara; R Yasuoka; Y Fujita; M Nakanishi; K Masuda; K Shimomura; Y Nakamura; J Inazawa; T Abe; H Yamagishi
Journal:  Br J Cancer       Date:  2001-03-23       Impact factor: 7.640

3.  Promoter hypermethylation of the Chfr gene in neoplastic and non-neoplastic gastric epithelia.

Authors:  T Honda; G Tamura; T Waki; S Kawata; S Nishizuka; T Motoyama
Journal:  Br J Cancer       Date:  2004-05-17       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.